NSD-IN-4

NSD-IN-4 (Compound A8) is an orally bioavailable, potent NSD3 inhibitor that triggers dose-dependent apoptosis. It exhibits robust antitumor efficacy in lung squamous cell carcinoma models, supporting its use in oncology research for both in vitro mechanistic studies and in vivo efficacy evaluations.